Recent advances in the molecular signaling pathways of Substance P in Alzheimer's disease: Link to neuroinflammation associated with toll-like receptors

被引:3
|
作者
Gurram, Prasada Chowdari [1 ,2 ]
Satarker, Sairaj [1 ]
Nampoothiri, Madhavan [1 ]
机构
[1] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Dept Pharmacol, Manipal 576104, Karnataka, India
[2] Koneru Lakshmaiah Educ Fdn, KL Coll Pharm, Vaddeswaram 522302, AP, India
关键词
Substance P; Alzheimer's disease; TLR; Neurokinin; Neurodegeneration; Neuroinflammation; AMYLOID PRECURSOR PROTEIN; MESSENGER-RNA EXPRESSION; NEUROKININ-1; RECEPTOR; IMMUNE-SYSTEM; TACHYKININS; CELLS; PEPTIDE; IMMUNOREACTIVITY; INTERLEUKIN-6; MODULATION;
D O I
10.1016/j.bbrc.2024.150597
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A significant quantity of substance P (SP) and its receptor, the neurokinin 1 (NK1) receptors are found in the brain. SP is a neuropeptide distributed in the central nervous system and functions as a neurotransmitter, neuromodulator, and neurotrophic factor. The concentrations of SP in the brain and cerebrospinal fluid fluctuate in individuals with Alzheimer's disease (AD). SP is an endogenous ligand for NK1 receptor, enhancing the expression of toll-like receptors (TLR) and vice versa. So, both pathways are interconnected, where activation of one pathway activates the second pathway. Researchers have observed the interaction of TLR with SP in the pathophysiology of AD. Thus, this review discusses various TLRs involved in regulating amyloid processing and its interaction with SP in AD. Further, in AD pathology, SP can regulate the non-amyloidogenic pathway. Recent studies have also demonstrated the capacity of SP in regulating voltage-gated potassium channel currents, emphasizing SP's neuroprotective ability. Therefore, we corroborate the findings linking the SP, NK1R, and TLRs in AD.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Toll-like receptors as a missing link in Notch signaling cascade during neurodevelopment
    Stojanovic, Mario
    Kalanj-Bognar, Svjetlana
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2024, 17
  • [32] Toll-Like Receptors, Associated Biochemical Signaling Networks, and S100 Ligands
    Gupta, Sahil
    Tsoporis, James N.
    Jia, Song-Hui
    dos Santos, Claudia C.
    Parker, Thomas G.
    Marshall, John C.
    SHOCK, 2021, 56 (02): : 167 - 177
  • [33] Toll-like receptors: Recent advances, open questions and implications for aspergillosis control
    Luther, Kathrin
    Ebel, Frank
    MEDICAL MYCOLOGY, 2006, 44 : S219 - S227
  • [34] Eicosanoid signaling in neuroinflammation associated with Alzheimer's disease
    Lohitaksha, Koppada
    Kumari, Deepika
    Shukla, Manas
    Byagari, Lavanya
    Ashireddygari, Vigneshwar Reddy
    Tammineni, Prasad
    Reddanna, Pallu
    Gorla, Madhavi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 976
  • [35] Translational mini-review series on Toll-like receptors: Recent advances in understanding the role of Toll-like receptors in anti-viral immunity
    Bowie, A. G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 147 (02): : 217 - 226
  • [36] Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies
    Cole, Jennifer E.
    Kassiteridi, Christina
    Monaco, Claudia
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (11) : 629 - 636
  • [37] Signaling danger:: Toll-like receptors and their potential roles in kidney disease
    Anders, HJ
    Banas, B
    Schlöndorff, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (04): : 854 - 867
  • [38] Molecular docking analysis of p53 with Toll-like receptors
    Alam, Mohammad Jahoor
    Bardakci, Fevzi
    Anjum, Sadia
    Mir, Shumayla Rasheed
    Ahmad, Irfan
    Saeed, Mohd
    BIOINFORMATION, 2021, 17 (09) : 784 - 789
  • [39] Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
    Shuanglin Deng
    Shan Zhu
    Yuan Qiao
    YongJun Liu
    Wei Chen
    Gang Zhao
    Jingtao Chen
    Protein & Cell, 2014, 5 (12) : 899 - 911
  • [40] Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
    Deng, Shuanglin
    Zhu, Shan
    Qiao, Yuan
    Liu, Yong-Jun
    Chen, Wei
    Zhao, Gang
    Chen, Jingtao
    PROTEIN & CELL, 2014, 5 (12) : 899 - 911